Company Filing History:
Years Active: 2013
Title: Jørg Hollidt: Innovator in Rheumatoid Arthritis Diagnosis
Introduction
Jørg Hollidt is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medical diagnostics, particularly in relation to rheumatoid arthritis. His innovative work has led to the development of a unique peptide that holds promise for improved diagnosis of this condition.
Latest Patents
Jørg Hollidt holds a patent for "HNRNP A3 related peptides and use thereof for diagnosis of rheumatoid arthritis." This invention pertains to a peptide and its retro or retro-inverso variants, which are characterized by a length of ≤25 amino acid residues. The peptide includes at least one citrulline residue and exhibits a sequence identity of ≥70% compared to the human hnRNP A3 protein (SEQ ID No. 1). This advancement could play a crucial role in the early detection and management of rheumatoid arthritis.
Career Highlights
Hollidt is affiliated with Charité – Universitätsmedizin Berlin, a prestigious medical institution known for its research and clinical excellence. His work at this institution has allowed him to focus on innovative solutions in the medical field, particularly in diagnostics.
Collaborations
Some of his notable coworkers include Karl Skriner and Kerstin Adolph. Their collaborative efforts contribute to the advancement of research and development in the medical sector.
Conclusion
Jørg Hollidt's contributions to the field of rheumatoid arthritis diagnosis through his patented peptide represent a significant step forward in medical innovation. His work continues to inspire advancements in diagnostic methods and patient care.